The U.S. artificial intelligence in healthcare market size is anticipated to reach USD 13.26 billion by 2033 and is expected to expand at a CAGR of 36.76% during the forecast period, according to a new report by Grand View Research, Inc. Technological, demographic, and systemic factors are propelling the market.

One of the primary drivers is the robust digital health infrastructure that characterizes the U.S. healthcare ecosystem. The widespread adoption of electronic health records (EHRs), the proliferation of telehealth platforms, and the integration of wearable devices have collectively generated vast datasets. These datasets are a foundation for training sophisticated AI models, enabling more accurate diagnostics, personalized treatment plans, and efficient clinical workflows.

Another significant factor contributing to market expansion is the increasing prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer. With six in ten Americans affected by at least one chronic illness, there is a growing demand for AI-enabled solutions supporting early detection, continuous monitoring, and effective disease management. This demand is further amplified by the aging population, which is projected to reach 82 million individuals aged 65 or older by 2050. AI technologies offer promising avenues to enhance long-term care and improve health outcomes for this demographic.

Supportive government initiatives and strategic investments from both established technology firms and emerging startups have also played a pivotal role in accelerating AI adoption in healthcare. Companies are channeling substantial funding into developing AI-powered diagnostic tools, workflow automation systems, and virtual care platforms. For instance, recent collaborations and product launches, such as Amazon One Medical's integration of AI into its proprietary EHR system, exemplify the industry's commitment to innovation and operational efficiency.

Furthermore, the growing need to reduce healthcare costs and address the shortage of medical professionals has intensified the focus on automation and predictive analytics. AI systems are increasingly deployed to streamline administrative tasks, optimize resource allocation, and support clinical decision-making. The integration of machine learning and natural language processing technologies is enhancing the capabilities of AI applications across various domains, including robot-assisted surgery, drug discovery, and remote patient monitoring. These advancements collectively underscore the transformative potential of AI in reshaping the future of healthcare delivery in the U.S.

Order a free sample PDF of the U.S. Artificial Intelligence In Healthcare Market Intelligence Study, published by Grand View Research.

Further key findings from the report suggest:

  • Based on component, the software solution segment held the highest market share of 44.19% in 2024.
  • Based on technology, the Machine Learning segment held the highest market share of 35.75% in 2024.
  • Based on application, the robot assisted surgery segment held the highest market share in 2024.
  • By end use, the pharmaceutical & biotechnology companies segment held the highest market share in 2024.

U.S. Artificial Intelligence In Healthcare Market Segmentation

Grand View Research has segmented the U.S. artificial intelligence in healthcare market based on component, application, technology, and end use.

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
    • Software Solutions
      • AI platform
        • Application Program Interface (API)
        • Machine Learning Framework
      • AI Solutions
        • On premise
        • Cloud based
    • Hardware
      • Processor
        • MPU (memory protection unit)
        • FPGA (Field-programmable gate array)
        • GPU (Graphics processing unit)
        • ASIC (Application-specific integrated circuit)
      • Memory (RAM ROM)
      • Network
        • Adapter
        • Interconnect
        • Switch
    • Services
      • Deployment & Integration
      • Support & Maintenance
      • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
    • Robot Assisted Surgery
    • Virtual Assistants
    • Administrative Workflow Assistants
    • Connected Medical devices
    • Medical Imaging & Diagnostics
    • Clinical Trials
    • Fraud Detection
    • Cybersecurity
    • Dosage Error Reduction
    • Precision medicine
    • Drug discovery & development
    • Lifestyle management & remote patient monitoring
    • Wearables
    • Others
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
    • Machine Learning
      • Deep learning
      • Supervised
      • Unsupervised
      • Others
    • NLP
      • Smart Assistance
      • OCR (Optical Character Recognition)
      • Auto Coding
      • Text analytics
        • Speech analytics
        • Classification and categorization
    • Computer Vision
    • Context-Aware Computing
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Hospitals & Healthcare providers
    • Healthcare payers
    • Pharmaceutical & Biotechnology Companies
    • Patients
    • Others

List of Key Players in the U.S. Artificial Intelligence In Healthcare Market

  • IBM Watson Health
  • Microsoft Corporation
  • Google Health
  • NVIDIA Corporation
  • Amazon Web Services (AWS)
  • Tempus AI
  • Aidoc
  • Eko Health Inc.
  • Hinge Health
  • Abridge

About Grand View Research:

Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.

For more information, visit www.grandviewresearch.com.